(Q48852672)

16 February 2018

title

An open clinical and biochemical study of ritanserin in acute patients with schizophrenia. (English)

1 reference

16 February 2018

1 reference

F A Wiesel

1

1 reference

16 February 2018

A L Nordström

series ordinal

2

1 reference

16 February 2018

L Farde

series ordinal

3

1 reference

16 February 2018

B Eriksson

series ordinal

4

1 reference

16 February 2018

publication date

1 February 1994

1 reference

16 February 2018

published in

Psychopharmacology

1 reference

16 February 2018

volume

114

1 reference

16 February 2018

page(s)

31-38

1 reference

16 February 2018

issue

1

1 reference

16 February 2018

https://scigraph.springernature.com/pub.10.1007/bf02245441

exact match

0 references

cites work

Negative v positive schizophrenia. Definition and validation.

1 reference

https://api.crossref.org/works/10.1007%2FBF02245441

The role of serotonin in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245441

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245441

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245441

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245441

Functional correlates of serotonin 5-HT1 recognition sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245441

Effects of ritanserin on sleep disturbances of dysthymic patients

21 January 2018

1 reference

12 December 2020

Mechanism of the antipsychotic effect in the treatment of acute schizophrenia

1 reference

12 December 2020

Effects of the 5-HT2 receptor antagonist, ritanserin, on biogenic amines in the rat nucleus accumbens

1 reference

12 December 2020

Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist

1 reference

12 December 2020

The role of serotonin in schizophrenia. New findings

1 reference

12 December 2020

Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects

1 reference

12 December 2020

Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method.

1 reference

12 December 2020

Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions.

1 reference

12 December 2020

A comprehensive psychopathological rating scale

1 reference

12 December 2020

A clinical assessment of zuclopenthixol dihydrochloride (Clopixol tablets) in the treatment of psychotic illness

1 reference

12 December 2020

Treatment of neuroleptic induced akathisia with the 5-HT2 antagonist ritanserin

1 reference

12 December 2020

Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers

1 reference

12 December 2020

An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET

1 reference

12 December 2020

Zetidoline, a new antipsychotic. First controlled trial in acute schizophrenia

1 reference

12 December 2020

A New Depression Scale Designed to be Sensitive to Change

1 reference

12 December 2020

5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin

1 reference

12 December 2020

Receptor occupancy by ritanserin and risperidone measured using ex vivo autoradiography

1 reference

12 December 2020

Clinical Evaluation of Sulpiride in Schizophrenic Patients - A Double-blind Comparison with Chlorpromazine

1 reference

12 December 2020

5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo.

1 reference

12 December 2020

Clinical profile of remoxipride--a combined analysis of a comparative double-blind multicentre trial programme

1 reference

12 December 2020

The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam

1 reference

12 December 2020

Ritanserin assessments in plasma and CSF by means of HPLC technique with fluorescence detection

1 reference

12 December 2020

Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations

1 reference

12 December 2020

A rating scale for extrapyramidal side effects

1 reference

12 December 2020

A Comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding

1 reference

12 December 2020

NOSIE-30: A Treatment-Sensitive Ward Behavior Scale

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02245441

1 reference

16 February 2018

PubMed ID

7846205

1 reference

16 February 2018